Hakan Kılıçaslan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hakan Kılıçaslan has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ali Özhan Sıvacı
Department of Neurology, University of Health Sciences, Bursa Yüksek Ihtisas Training and Research Hospital, Bursa, Türkiye
1 shared publication - Meral Seferoğlu
Department of Neurology, University of Health Sciences, Bursa Yüksek Ihtisas Training and Research Hospital, Bursa, Türkiye
1 shared publication - Murat Kaan Yılmaz
Mudanya University, Bursa, Turkiye
1 shared publication - Yelda Fırat
Department of Computer Engineering, Artvin Çoruh University, Artvin 08000, Türkiye
1 shared publication - Yılmaz Kılıçaslan
Department of Artificial Intelligence and Data Engineering, Istanbul Atlas University, Istanbul 34403, Türkiye
1 shared publication
Latest Publications
- Open Access
- 3 November 2025
- Published by The European Research Journal in The European Research Journal
- Vol. 11 (6) , 1213-1226
Artificial intelligence-based handwriting analysis for non-invasive multiple sclerosis detection: A preliminary study
Objectives: Multiple sclerosis (MS) is a chronic central nervous system disorder that causes demyelination, inflammation, and axonal damage, leading to permanent disabilities in motor, sensory, visual, and balance functions. This study aimed to develop an artificial intelligence (AI)-based, non-invasive diagnostic approach for MS detection using handwriting analysis, leveraging deep learning methods to identify disease-specific handwriting patterns. Methods: A classification model was designed using a convolutional neural network (CNN) based on the VGG16 architecture with transfer learning. The dataset consisted of 426 handwriting samples, including 213 from MS patients and 213 from healthy individuals. Data augmentation and early stopping techniques were employed to improve model generalization capability. Results: The proposed model achieved a validation accuracy of 83.72% and a test accuracy of 85%, indicating its robustness in distinguishing MS patients from healthy subjects. The confusion matrix analysis demonstrated a sensitivity of 86% and a specificity of 84%, indicating moderate discriminatory performance. Conclusions: The findings suggest that the developed AI-based model offers an effective, non-invasive diagnostic tool for MS detection. This approach provides a promising foundation for future research on monitoring disease progression and developing clinically applicable AI-supported diagnostic systems.
- 3 November 2025
- Published by The European Research Journal in The European Research Journal
- Vol. 11 (6) , 1213-1226
Open AccessArtificial intelligence-based handwriting analysis for non-invasive multiple sclerosis detection: A preliminary study
Objectives: Multiple sclerosis (MS) is a chronic central nervous system disorder that causes demyelination, inflammation, and axonal damage, leading to permanent disabilities in motor, sensory, visual, and balance functions. This study aimed to develop an artificial intelligence (AI)-based, non-invasive diagnostic approach for MS detection using handwriting analysis, leveraging deep learning methods to identify disease-specific handwriting patterns. Methods: A classification model was designed using a convolutional neural network (CNN) based on the VGG16 architecture with transfer learning. The dataset consisted of 426 handwriting samples, including 213 from MS patients and 213 from healthy individuals. Data augmentation and early stopping techniques were employed to improve model generalization capability. Results: The proposed model achieved a validation accuracy of 83.72% and a test accuracy of 85%, indicating its robustness in distinguishing MS patients from healthy subjects. The confusion matrix analysis demonstrated a sensitivity of 86% and a specificity of 84%, indicating moderate discriminatory performance. Conclusions: The findings suggest that the developed AI-based model offers an effective, non-invasive diagnostic tool for MS detection. This approach provides a promising foundation for future research on monitoring disease progression and developing clinically applicable AI-supported diagnostic systems.